In February 2018, regulations setting out a framework to protect patients from the hazards associated with medical exposure to ionising radiation came into force in Great Britain and Northern Ireland.

MEG joined working parties established by professional bodies to update two separate IR(ME)R guidance documents for diagnostic imaging, nuclear medicine and radiotherapy exposures:

The two national guidance documents are intended to support all staff groups involved in medical and non-medical exposures, and to enhance patient safety when ionising radiation is used in the clinical setting. The guidance explains how the regulations should be interpreted in clinical practice in both the NHS and independent sector. It also extends to research laboratories, universities and sports facilities where medical and non-medical exposures are undertaken. The inclusion of diagnostic nuclear medicine and molecular radiotherapy exposures has now provided the nuclear medicine community with guidance on IR(ME)R.